Form 483

UNIVERSITY OF CALIFORNIA, LOS ANGELES Form 483, 2020-07-31

FDA issued a Form 483 to UNIVERSITY OF CALIFORNIA, LOS ANGELES on 2020-07-31 with 14 public-safe observations.

483· Form 483 issuedHuman Drugs14 observations

UNIVERSITY OF CALIFORNIA, LOS ANGELES · Los Angeles, United States · Issued July 31, 2020

Overview

  • 14 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Jul 2020
21 CFR 212.110(c)

Record retention period

Cited by Jeffrey P Raimondi, Linda F Murphy

31 Jul 2020
21 CFR 212.110(c)

Record retention period

Cited by Jeffrey P Raimondi, Linda F Murphy

31 Jul 2020
21 CFR 212.20(e)

Written QA procedures established, followed

Cited by Jeffrey P Raimondi, Linda F Murphy

31 Jul 2020
21 CFR 212.20(e)

Written QA procedures established, followed

Cited by Jeffrey P Raimondi, Linda F Murphy

31 Jul 2020
21 CFR 212.30(b)

Equipment procedures

Cited by Jeffrey P Raimondi, Linda F Murphy

Inspected site

UOUNIVERSITY OF CALIFORNIA, LOS ANGELESLos Angeles, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.110(c)Cited across public-safe Form 483 observations2x
21 CFR 212.20(e)Cited across public-safe Form 483 observations2x
21 CFR 212.30(b)Cited across public-safe Form 483 observations2x
21 CFR 212.40(a)Cited across public-safe Form 483 observations2x
21 CFR 212.60(c)Cited across public-safe Form 483 observations2x
21 CFR 212.60(g)Cited across public-safe Form 483 observations2x
21 CFR 212.70(b)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 14 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere